Literature DB >> 180209

Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.

R M Friedman, J C Costa, J M Ramseur, M W Meyers, F T Jay, E H Chang.   

Abstract

In AKR mouse cells chronically infected with a murine leukemia virus, treatment with interferon for nine days resulted in sustained inhibition of extracellular production of murine leukemia virus but no inhibition of viral intracellular p30 antigen or of reverse transcriptase. Removal of interferon resulted in rapid reversal of these effects. Interferon-treated mouse L-cells were infected with high multiplicities of vesicular stomatitis virus or herpes simplex virus type 1. Infectious virus and intracellular viral antigen were rapidly eliminated from the interferon-treated cultures infected with herpes simplex virus. In cultures infected with vesicular stomatitis virus, titers of virus remained low in interferon-treated cells, but after about two weeks they rose rapidly and the cultures were destroyed. If treatment with interferon was reinstituted as late as nine days after primary infection, infectious vesicular stomatitis virus was eliminated, and there was no evidence for survival of the viral genome in these cultures. In the cultures infected with murine leukemia virus, inhibition of production of virus by treatment with interferon was possible, but the viral genome was not eliminated. In cells acutely infected with vesicular stomatitis virus or herpes simplex virus, however, the viral genomes were apparently eliminated from cultures treated with interferon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180209     DOI: 10.1093/infdis/133.supplement_2.a43

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon.

Authors:  G B Rossi; A Dolei; L Cioé; A Benedetto; G P Matarese; F Belardelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.

Authors:  J Laurence; J Kulkosky; S M Friedman; D N Posnett; P O Ts'o
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus.

Authors:  S Salzberg; M Bakhanashvili; S Bari; I Berman; M Aboud
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Effects of exogenous interferon on L cells persistently infected with Sendai virus.

Authors:  Y Ito; Y Nishiyama; K Shimokata; K Maeno
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  Interferon inhibits C-type virus at a posttranscriptional, prerelease step.

Authors:  A Billiau; H Heremans; P T Allens; S Baron; P de Somer
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

6.  Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell cultures.

Authors:  S M Hammer; J C Kaplan; B R Lowe; M S Hirsch
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.